Retinalamin

Retinalamin (catalog RETINALAMIN) is supplied as a laboratory research reference material intended solely for in-vitro and laboratory research use. The item is offered as a synthetic preparation presented as a white to off-white lyophilized powder, packaged to support reconstitution in solvent systems appropriate to the investigator's analytical workflow. Because the material is a low-molecular-weight peptide fraction rather than a single defined sequence, Retinalamin is characterized in aggregate by molecular weight of less than 10 kDa, a property consistent with polypeptide complexes described in the published literature under this common name.

Compositionally, Retinalamin belongs to the family of retinal polypeptide complexes: heterogeneous mixtures of short peptides and oligopeptide fragments in the sub-10 kDa range. This distribution has direct implications for analytical handling. Size exclusion chromatography, SDS-PAGE with low-molecular-weight standards, MALDI-TOF mass spectrometry, and UV absorbance at 280 nm and 214 nm are commonly employed to profile such mixtures, while reversed-phase HPLC serves as the primary purity-tracking method. For Retinalamin, purity is specified as not less than 98% by HPLC, with the exact chromatographic profile, lot number, and identity confirmation documented on the lot-specific Certificate of Analysis available on request.

Formulators and analytical chemists working with lyophilized peptide fractions typically evaluate solubility across aqueous buffers of varying ionic strength and pH, sterile water, and mildly acidic diluents, and assess stability under controlled temperature and light exposure. As with most lyophilized peptide reference materials, storage at reduced temperature in a sealed, desiccated environment supports long-term integrity of the powder, and reconstituted aliquots are generally handled to minimize freeze-thaw cycling. These are analytical considerations only and are not instructions for administration.

Retinalamin has been referenced in preclinical scientific literature, and this listing is provided to support bench-scale characterization, method development, and comparative analytical studies. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding Retinalamin and provides no administration or dosing guidance of any kind. This material is not a drug, supplement, cosmetic, or food, and is not intended for human or veterinary use, injection, or ingestion. All identity, purity, and quality parameters are traceable through the lot-specific Certificate of Analysis.

Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.

Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.

This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.